Nu Skin Names Chelsea Lantz Interim CFO After James Thomas Steps Down

NUS
March 21, 2026

Nu Skin Enterprises announced that James Thomas, who had served as chief financial officer for 16 years, stepped down from the role on March 17, 2026, to pursue an outside opportunity. The company named Chelsea Lantz, its corporate controller since 2023, as interim chief financial officer effective March 18, 2026.

Lantz joined Nu Skin in 2011 and has led the company’s cost‑improvement program that lifted earnings per share from $0.84 in 2024 to $1.27 in 2025, a 51% increase, while improving gross margin from 62.7% to 70.7% and operating margin from –11.9% to 6.3%. Her appointment is intended to preserve continuity as Nu Skin accelerates its transformation into an intelligent wellness platform.

The transition comes as Nu Skin reports a 14.3% decline in full‑year 2025 revenue to $1.49 billion, down from $1.75 billion in 2024, and a 9% to 1% decline in 2026 revenue guidance of $1.35 billion to $1.50 billion. The company’s EPS guidance for 2026 is $0.80 to $1.20, reflecting a focus on margin expansion and cost discipline amid top‑line pressure.

Nu Skin’s Q4 2025 results showed revenue of $370.3 million, a 16.9% year‑over‑year decline, and EPS of $0.29, narrowly missing consensus estimates of $0.30. The miss was largely driven by a 16.9% drop in revenue, offset by a 70.7% gross margin that improved from 62.7% in Q4 2024, and an operating margin that swung from –11.9% to 6.3% due to disciplined cost control.

Management highlighted the launch of the Prysm iO, an AI‑powered nutritional wellness platform introduced in Q4 2025 and slated for a broader consumer rollout in 2026, as a key driver of future growth. CEO Ryan Napierski said the company is “building sales leader alignment around the global launch of Prysm iO, positioning us for a return to year‑over‑year revenue growth by year’s end.”

The CFO change signals confidence in the finance team’s ability to navigate the company’s strategic shift. Lantz will oversee capital allocation, debt reduction, and the execution of the company’s margin‑improvement initiatives while the board searches for a permanent replacement.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.